ES2058486T3 - Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis. - Google Patents

Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis.

Info

Publication number
ES2058486T3
ES2058486T3 ES89300328T ES89300328T ES2058486T3 ES 2058486 T3 ES2058486 T3 ES 2058486T3 ES 89300328 T ES89300328 T ES 89300328T ES 89300328 T ES89300328 T ES 89300328T ES 2058486 T3 ES2058486 T3 ES 2058486T3
Authority
ES
Spain
Prior art keywords
group
immunogens
tenella
coccidiosis
recombinants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89300328T
Other languages
English (en)
Inventor
Paul A Liberator
Karl H Nollstadt
Mervyn J Turner
John Crane Mark St
Yashwant D Karkhanis
Prasanta R Chakraborty
Profous-Juchelka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2058486T3 publication Critical patent/ES2058486T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE HAN AISLADO GENES QUE CODIFICAN NUEVOS INMUNOGENOS PROTEINICOS DE EIMERIA TENELLA DEL GRUPO B Y SE HAN INSERTADO EN UN NUEVO VECTOR DE EXPRESION QUE A SU VEZ SE HA USADO PARA TRANSFORMAR HUESPEDES APROPIADOS. LAS CELULAS HUESPED TRANSFORMADAS PRODUCEN PROTEINAS RECOMBINANTES DE E. TENELLA DEL GRUPO B, QUE SON CAPACES DE INDUCIR INMUNIDAD A LA COCCIDIASIS EN POLLOS. EL ANTICUERPO CONTRA LOS INMUNOGENOS PROTEINICOS RECOMBINANTES PREPARADO, SE EMPLEA PARA AISLAR E IDENTIFICAR LA PROTEINA NATIVA DE OOCISTOS ESPORULADOS DE E. TENELLA.
ES89300328T 1988-01-15 1989-01-13 Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis. Expired - Lifetime ES2058486T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14580288A 1988-01-15 1988-01-15
US28693688A 1988-12-22 1988-12-22

Publications (1)

Publication Number Publication Date
ES2058486T3 true ES2058486T3 (es) 1994-11-01

Family

ID=26843302

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89300328T Expired - Lifetime ES2058486T3 (es) 1988-01-15 1989-01-13 Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis.

Country Status (8)

Country Link
EP (1) EP0337589B1 (es)
JP (1) JPH0235085A (es)
AU (1) AU623624B2 (es)
CA (1) CA1340858C (es)
DE (1) DE68907254T2 (es)
ES (1) ES2058486T3 (es)
IE (1) IE62866B1 (es)
NZ (1) NZ227597A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279960A (en) * 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
EP0373168B1 (en) * 1987-03-06 1996-11-13 Amgen Boulder Inc. Polypeptide useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
NZ227595A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Recombinant production of eimeria tenella antigens and their use
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
CA2106093A1 (en) * 1991-03-14 1992-09-15 David E. Harwood Recombinant anticoccidial vaccine
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
ES2253746T3 (es) 1995-07-03 2006-06-01 Akzo Nobel N.V. Vacuna contra la coccidiosis aviar.
NZ500033A (en) * 1998-10-07 2001-06-29 Akzo Nobel Nv Hydrophilic eimeria polypeptides for use as coccidiosis vaccines
US6680061B1 (en) 1998-10-07 2004-01-20 Theodorus Cornelis Schaap Coccidiosis vaccines
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
DE102008054533B8 (de) 2007-12-26 2013-02-14 Denso Corporation Ultraschallsensor
CN111518788B (zh) * 2020-05-19 2022-11-08 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种柔嫩艾美耳球虫敏感株与耐药株的分子标记及其应用
CN114380474B (zh) * 2021-12-21 2022-10-21 佛山市正典生物技术有限公司 粪便处理剂及其处理含鸡盲肠芯粪便的方法和应用
CN120570920B (zh) * 2025-05-30 2026-04-10 吉林农业大学 产丁酸肠杆菌作为抗柔嫩艾美耳球虫的益生菌的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135073A3 (en) * 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozites of eimeria spp.
CA1340520C (en) * 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
WO1986000528A1 (en) * 1984-07-05 1986-01-30 Genex Corporation Cloned gene and method for making and using the same
JPS61120322A (ja) * 1984-11-15 1986-06-07 Fuji Photo Film Co Ltd ヘツドクリ−ニング用フレキシブルデイスク
DE3650540T2 (de) * 1985-12-03 1997-02-27 Solvay Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
EP0373168B1 (en) * 1987-03-06 1996-11-13 Amgen Boulder Inc. Polypeptide useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
ZA902147B (en) * 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
DE68909041T2 (de) * 1989-06-21 1994-01-13 Akzo Nv Eimeria tenella-Vakzin.

Also Published As

Publication number Publication date
IE62866B1 (en) 1995-03-08
CA1340858C (en) 1999-12-21
AU2854289A (en) 1989-07-20
NZ227597A (en) 1991-11-26
DE68907254D1 (de) 1993-07-29
IE890101L (en) 1989-07-15
JPH0235085A (ja) 1990-02-05
EP0337589B1 (en) 1993-06-23
EP0337589A2 (en) 1989-10-18
EP0337589A3 (en) 1989-10-25
AU623624B2 (en) 1992-05-21
DE68907254T2 (de) 1993-12-09

Similar Documents

Publication Publication Date Title
ES2058486T3 (es) Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis.
ES2091861T3 (es) Proteinas antigenicas y vacunas que las contienen para la prevencion de la coccidiosis.
ES2150916T3 (es) Utilizacion del acido gentisico o del alcohol gentisilico para estabilizar peptidos y proteinas radiomarcados.
ATE280234T1 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
ATE195347T1 (de) Methoden der erhöhung der sekretion von überexpremierten proteinen
MX9206041A (es) Proceso para producir interferon inmune humano.
ES2061482T3 (es) Metodo para la identificacion de secuencias de señal secretora para sintesis de proteina extracelular en bacillus.
ES2072900T3 (es) Expresion elevada de proteinas en levadura.
EA202090757A1 (ru) T-КЛЕТОЧНЫЕ РЕЦЕПТОРЫ, РАСПОЗНАЮЩИЕ МУТАНТНЫЙ p53
ES8703490A1 (es) Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano
ATE236261T1 (de) Dna-expressionssysteme basierend auf alphaviren
ES8705467A1 (es) Un procedimiento para producir la proteina apoacuorina
DK163683D0 (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykkedna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
UY25877A1 (es) Antígenos estreptococo
ES8306797A1 (es) Un metodo para producir un polipeptido.
ES8801851A1 (es) Un metodo para producir bacterianamente un polipeptido heteralogo que tiene actividad somatotropinica.
ES8802394A1 (es) Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana.
ES2174835T3 (es) Carboxilasa dependiente de la vitamina k.
ES2062982T3 (es) Clonaje y expresion del factor de crecimiento de fibroblasto acido.
BR112017022076A2 (pt) fusões de mesotelina-variante iii de receptor de fator de crescimento epidérmico e métodos de uso das mesmas
ES2111536T3 (es) Metodos y secuencias de acidos nucleicos para la expresion del operon de la sintasa de celulosa.
EA202092065A1 (ru) ЭКСПРЕССИЯ ПНЕВМОКОККОВОГО ПОВЕРХНОСТНОГО БЕЛКА А (PspA)
BR112022022615A2 (pt) Proteína nova e usos terapêuticos e cosméticos da mesma
ES2065915T3 (es) Procedimiento para aumentar la expresion de polipeptidos en un cultivo de celula recombinante.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 337589

Country of ref document: ES